Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,318 | 187,864 | 164,627 | 118,370 | 274,227 |
| Marketable Securities | 511,988 | 341,166 | 298,824 | 217,630 | 209,055 |
| Receivables | 285,743 | 214,524 | 195,902 | 234,210 | 217,325 |
| Inventories | 131,412 | 159,312 | 168,541 | 127,601 | 128,921 |
| TOTAL | $1,126,976 | $987,797 | $873,584 | $746,424 | $879,006 |
| Non-Current Assets | |||||
| PPE Net | 74,490 | 75,000 | 78,071 | 74,944 | 74,669 |
| Intangibles | 836,413 | 854,175 | 871,937 | 889,700 | 907,462 |
| Other Non-Current Assets | 80,151 | 52,481 | 17,935 | 22,202 | 31,525 |
| TOTAL | $991,054 | $981,656 | $967,943 | $986,846 | $1,013,656 |
| Total Assets | $2,118,030 | $1,969,453 | $1,841,527 | $1,733,270 | $1,892,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,398 | 15,430 | 13,325 | 11,816 | 19,318 |
| Accrued Expenses | 96,417 | 117,930 | 118,314 | 100,678 | 95,200 |
| TOTAL | $108,815 | $133,360 | $131,639 | $112,494 | $115,185 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,504,154 | 1,502,515 | 1,500,879 | 1,499,248 | 1,497,621 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 667 |
| Other Non-Current Liabilities | 40,406 | 30,507 | 31,201 | 37,720 | 28,422 |
| TOTAL | $1,556,512 | $1,546,669 | $1,532,080 | $1,536,968 | $1,528,296 |
| Total Liabilities | $1,665,327 | $1,680,029 | $1,663,719 | $1,649,462 | $1,643,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,227 | 126,678 | 127,274 | 126,825 | 132,098 |
| Common Shares | 127 | 127 | 127 | 127 | 132 |
| Retained earnings | 397,629 | 260,618 | 167,373 | 90,550 | 222,285 |
| Other shareholders' equity | -6,939 | -2,068 | -1,486 | -9,278 | 1,227 |
| TOTAL | $452,703 | $289,424 | $177,808 | $83,808 | $249,181 |
| Total Liabilities And Equity | $2,118,030 | $1,969,453 | $1,841,527 | $1,733,270 | $1,892,662 |